Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triplet vs Doublet Chemotherapy with Targeted Therapy in Metastatic Colorectal Cancer (PRODIGE 14)
NCT01442935Phase 2Completed
- Sponsor
- Unicancer
- Start
- Feb 2011
- Primary completion
- Dec 2015
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, irinotecan, fluorouracil, folinic acid in metastatic colorectal cancer (mCRC), sponsored by Unicancer. Started Feb 2011; status: completed.
02
Drugs
oxaliplatinirinotecanfluorouracilfolinic acid
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01442935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01442935.